BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 31/03/2026

FDA Announces Decision on Hearing Request for TRADIPITANT Capsules Approval

The FDA has announced its decision on a request for a hearing regarding a proposal to refuse approval of a new drug application for TRADIPITANT capsules, submitted by Vanda Pharmaceuticals, Inc. for the treatment of gastroparesis symptoms.

Source: Federal Register — Food and Drug AdministrationOpen original release →